N
ALT icon

Nuveen’s Altimmune ALT Stock Holding History

Nuveen’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.19M Buy
2,334,601
+1,090,390
+88% +$4.63M ﹤0.01% 1728
2025
Q4 		$4.49M Buy
1,244,211
+1,041,856
+515% +$4.54M ﹤0.01% 1955
2025
Q3 		$763K Hold
202,355
– – ﹤0.01% 2744
2025
Q2 		$783K Sell
202,355
-61,543
-23% -$333K ﹤0.01% 2706
2025
Q1 		$1.3M Buy
263,898
+46,972
+22% +$298K ﹤0.01% 2512
2024
Q4 		$1.56M Sell
216,926
-17,504
-7% -$134K ﹤0.01% 2487
2024
Q3 		$1.44M Sell
234,430
-430,628
-65% -$2.92M ﹤0.01% 2589
2024
Q2 		$4.42M Sell
665,058
-247,942
-27% -$1.83M ﹤0.01% 2015
2024
Q1 		$9.29M Sell
913,000
-814,316
-47% -$8.28M ﹤0.01% 1640
2023
Q4 		$19.4M Sell
1,727,316
-1,719,462
-50% -$7.18M 0.01% 1180
2023
Q3 		$8.96M Sell
3,446,778
-12,171
-0.4% -$34.9K ﹤0.01% 1540
2023
Q2 		$12.2M Buy
3,458,949
+190,888
+6% +$857K ﹤0.01% 1382
2023
Q1 		$35.7M Buy
3,268,061
+2,098
+0.1% +$24.9K 0.01% 710
2022
Q4 		$53.7M Buy
3,265,963
+52,063
+2% +$585K 0.02% 516
2022
Q3 		$41M Buy
3,213,900
+149,620
+5% +$2.21M 0.02% 607
2022
Q2 		$35.9M Sell
3,064,280
-180,924
-6% -$1.12M 0.01% 698
2022
Q1 		$22.2M Buy
3,245,204
+949,372
+41% +$6.99M 0.01% 1138
2021
Q4 		$19.4M Buy
2,295,832
+1,490,012
+185% +$15.8M 0.01% 1248
2021
Q3 		$12.3M Buy
805,820
+567,253
+238% +$6.9M ﹤0.01% 1639
2021
Q2 		$2.35M Buy
+238,567
New +$3.26M ﹤0.01% 2630

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen's ALT Position: Q1 2026 in Review

Nuveen increased its Altimmune (ALT) stake by 88% in Q1 2026, buying an estimated $4.63M and bringing the position to 2,334,601 shares worth $7.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1728.

Nuveen first reported a position in ALT in Q2 2021 and has held it in 20 quarters since. The position peaked at $53.7M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Nuveen held 2,334,601 shares of Altimmune worth $7.19M as of Q1 2026.
  • Nuveen bought 1,090,390 Altimmune shares in Q1 2026, an estimated $4.63M.
  • Altimmune made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #1728 holding.
  • Nuveen first reported a position in Altimmune in Q2 2021 and has held it in 20 quarters since.
  • Nuveen's Altimmune position peaked at $53.7M in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.